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Abstract This paper resulted from a conference entitled
“Lactation and Milk: Defining and refining the critical ques-
tions” held at the University of Colorado School of Medi-
cine from January 18–20, 2012. The mission of the
conference was to identify unresolved questions and set
future goals for research into human milk composition,
mammary development and lactation. We first outline the
unanswered questions regarding the composition of human
milk (Section I) and the mechanisms by which milk com-
ponents affect neonatal development, growth and health and
recommend models for future research. Emerging questions
about how milk components affect cognitive development
and behavioral phenotype of the offspring are presented in
Section II. In Section III we outline the important
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unanswered questions about regulation of mammary gland
development, the heritability of defects, the effects of ma-
ternal nutrition, disease, metabolic status, and therapeutic
drugs upon the subsequent lactation. Questions surrounding
breastfeeding practice are also highlighted. In Section IV
we describe the specific nutritional challenges faced by
three different populations, namely preterm infants, infants
born to obese mothers who may or may not have gestational
diabetes, and infants born to undernourished mothers. The
recognition that multidisciplinary training is critical to ad-
vancing the field led us to formulate specific training rec-
ommendations in Section V. Our recommendations for
research emphasis are summarized in Section VI. In sum,
we present a roadmap for multidisciplinary research into all
aspects of human lactation, milk and its role in infant nutri-
tion for the next decade and beyond.
Keywords Lactation . Infant nutrition . Humanmilk .
Breastfeeding . Mammary gland development . Human
nutrition . Preterm birth . Obesity . Undernutrition .
Lactational programming . Milk
Abbreviations
AA Arachidonic acid
DHA Docosahexaenoic acid
ELBW Extremely low birth weight, <1,000 g birth
weight
GI Gastrointestinal
HFD High fat diet
HMO Human milk oligosaccharides
IL-10 Interleukin-10
LC-PUFA Long chain poly unsaturated fatty acids
NEC Necrotizing enterocolitis
NICU Neonatal intensive care unit
sIgA Secretory immunoglobulin A
TGF Transforming growth factor
VLBW Very low birth weight, <1,500 g birth weight
Introduction and Impact
“Mothers and infants form a biological and social unit;
they also share problems of malnutrition and ill-
health” [WHO, Infant and Young Child Nutrition:
Global Strategy on infant and young child feeding.
2012]
From an evolutionary, nutritional and economic stand-
point, human milk is the ideal food for the human infant for
the first months of life. Exclusive breastfeeding for the first
6 months followed by breastfeeding supplemented with
appropriate complementary foods for 1 year or longer con-
tinues to be the recommendation of the American Academy
of Pediatrics (AAP) [1], Centers for Disease Control and
Prevention (CDC) [2] and the World Health Organization
[3]. In the US these recommendations are currently met by
only 13 % of mothers leading to multiple initiatives by these
agencies to improve the rates of breastfeeding initiation,
duration and exclusivity. An important strategy is advocacy
for “baby friendly hospitals” [3] to improve breastfeeding
practices in US hospitals and communities. However, it is
possible that a focus on specific populations for which
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feeding human milk makes a critical difference would have
the most impact.
Milk is a complex fluid that exerts effects far beyond its
nutritional value. Yet even its composition is not well-
defined. A full appreciation of the range of nutritive and
non-nutritive components of milk and their secretion could be
translated into actionable policies that could impact the initi-
ation, duration and exclusivity of breastfeeding as well as
contribute to the intelligent design of human milk substitutes.
Even prior to conception, the health and nutritional status
of the mother have a profound influence on fetal develop-
ment and that of the mammary gland [4, 5]. The timing of
birth [6], obesity [7], maternal undernutrition [8] and other
maternal health problems [4, 9] are major factors that influ-
ence the nutritional needs and health of the neonate. For
these reasons the role of human milk in infant nutrition must
be studied in light of the changing dynamic that exists a
between mother and her child from before conception
through pregnancy and into postnatal life (Fig. 1). In addi-
tion, a clear understanding of the factors that affect the
ability of the mother to produce sufficient milk of appropri-
ate composition for her infant is critical in developing
evidence-based programs/policies to support breastfeeding.
Economic Impact The financial impact of improving neo-
natal nutrition in at-risk populations is enormous. One major
impact pertains to the consequences of preterm birth. It is
estimated that 65,000 very low birth weight infants (birth
weight <1,500 g) are born in the United States each year. If
the average hospital cost for mother and infant is ~$140,000
(RW Hall, personal communication), the total annual cost in
the US is more than $9 billion. If feeding human milk or its
important components reduced the incidence of necrotizing
enterocolitis (NEC) and other serious medical problems by
even 15 %, savings of over $1 billion per year could be
realized. A similar economic impact could be realized if the
obesity epidemic were reduced. The economic burden of
this epidemic is considered to have four elements, namely,
increased costs of medical care, costs of lost productivity,
transportation costs, and human capital accumulation [10]
estimated together to cost at least $250 billion per year. If
breastfeeding reduced the incidence of obesity in susceptible
individuals by even 10 % then savings of up to $25 billion
could be realized. A third area of high impact is that of
malnutrition on a global scale. Malnutrition affects 900
million children and their mothers, with an inestimable
economic impact. If the balance of feeding human milk
and complementary foods were optimized to minimize
growth stunting in the first two years in these individuals,
the impact would be enormous [8].
Social Impact Despite national and international initiatives
on breastfeeding, we lack an in depth understanding of both
the biological and psychosocial aspects of breastfeeding.
Studies of the mechanisms by which milk components af-
fect all aspects of infant development are in their infancy,
but it is increasingly clear that at-risk infants have special
nutritional needs and that, for such infants, the current
uniform breastfeeding recommendations are sub-optimal.
These deficits seriously impact the information available to
health care providers and families alike. Such knowledge
could be translated into science-based consumer information
and professional “toolkits” to help more women successful-
ly meet their own breastfeeding goals and achieve the best
nutrition for their infants.
In this paper we outline the specific questions that arose at
this wide-ranging conference as being important for research
in the next decade. These questions focus on the composition
Fig. 1 The first 1,000 days.
The crucial periods in infant
metabolic and cognitive
development are thought to
occur during the first
1,000 days of fetal/infant life
and can be divided into three
phases: pregnancy, breast (or
formula) feeding, and a period
of increasing complementary
feeding. General maternal/fetal
and maternal/infant interactions
are indicated for each phase
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of milk, the effects of milk components on neonatal develop-
ment, the regulation of mammary development and milk
secretion, and finally problems specific to at-risk populations.
Summary of Workshop Proceedings
Topic I Human Milk Components and their Function
a. What is the composition of human milk?
b. What are the detailed mechanism by which milk
components promote neonatal development?
c. What is the role of human milk in establishing the
infant microbiome?
d. How do environmental agents and pharmaceuticals
in milk affect infant development?
e. What is the role of the dairy products in infant
nutrition?
Topic II Effects of milk on behavioral and cognitive
development
a. What are the components of milk that affect cogni-
tive development and how do they work?
b. What elements of breastfeeding affect behavioral
phenotype?
c. Methods for studying the effects of milk on cogni-
tive and behavioral development.
Topic III Maternal factors affecting milk volume and
composition.
a. How do hormones and metabolism coordinately
program the mammary gland for lactation?
b. What are the genetic and epigenetic elements that
affect heritability of mammary gland development
and lactation-related traits?
c. What are the mechanisms by which maternal nutri-
tion, disease, and metabolic status affect milk com-
position and volume?
d. What breastfeeding practices prevent inadequate
lactation performance?
e. How do environmental agents and pharmaceuticals
affect milk volume and composition?
Topic IV Breastfeeding and the at-risk neonate
a. What is the role of human milk in the nutrition of
the preterm infant?
b. What is the role of breastfeeding in preventing
obesity in susceptible populations?
c. What is the role of human milk in preventing growth
stunting?
d. A community approach to lactation studies in at-risk
human populations.
Topic V Training the future lactation biologist
Topic VI Imperatives for advancing the field
Topic I: Human Milk Components and Their Function
Defining the composition of milk and the specific individual
and combined effects of its components on infant outcomes
is fundamental to optimizing the survival, health, and de-
velopment of the neonate in clinical and other settings.
Human milk is complex [11] and has a host of non-
nutritive functions including protection against infection,
reducing inflammation [12], promoting intestinal, immune
and cognitive development, and stimulating establishment
of the unique gut microbiome of the breastfed infant [13,
14]. In this section we summarize what is known about
human milk composition and its variation, where we are
with our knowledge of the function of milk components, the
role of the microbiome in infant development, and the
potential effects of drugs and toxins on the infant.
a. What is the composition of human milk?
(Contributors: German, Lemay, Lebrilla)
Research Target: A complete analysis of the struc-
ture and concentration of human milk components
as well as factors influencing their variability be-
tween women and throughout lactation.
New analytical tools that provide more quantitative and
sensitive methods have become available over the last decade
[15–17] and are revolutionizing our understanding of the
diversity of molecules in milk. These tools can now be used
to provide a catalogue of the structure of all proteins, oligo-
saccharides, glycoconjugates, metabolites, lipids and polynu-
cleotides (RNA, DNA) in the various fractions of milk.
Methods Advantage should be taken of large epidemiolog-
ical studies to bank samples of human milk at defined
intervals postpartum. Analyzing cellular mRNA present in
the cytoplasmic crescents of the milk fat globule provides a
window into the transcriptome of the mammary alveolar cell
in lactating women [18] that can be used to dissect the
effects of maternal states such as obesity and stress on
mammary cell function. For this reason particular impor-
tance should be given to proper sampling and storage of the
lipid fraction of milk. It is also essential that the collection
and storage of these milk samples be accompanied by sys-
tematically recorded detailed information regarding the
health, nutrition, immune function and reproductive state
of the woman providing the sample as well as the growth
and development of her infant.
b. What are the detailed mechanisms by which milk com-
ponents promote neonatal development? (Contributors:
Donovan, Contractor, Goldman, Meier, Forman)
Research Target: A detailed knowledge of the func-
tional mechanisms by which milk components acting
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both individually and together, promote intestinal
maturation, protect against infection and inflamma-
tion, and stimulate immune development in the infant.
In general, the variations in milk composition as well as
the mechanism of action of many bioactive components of
human milk in the infant remain poorly characterized al-
though these factors contribute significantly to infant devel-
opment [12]. Where certain constituents are low or lacking
in the milk of particular mothers, opportunities for supple-
mentation may exist. For infants whose mothers are unable
to breastfeed, a greater understanding of bioactive factors
may help improve the development of human milk substi-
tutes in relation to infant health. Thus a fuller appreciation of
the range of function of the nutritive and non-nutritive
components of human milk has significant potential to
translate to improved public health.
Most studies have focused on comparing human milk and
formula. However, by 6 months of age, most infants are
receiving both maternal milk and infant formula. How this
combined feeding strategy impacts resistance of the infant to
infection and other aspects of development is virtually un-
known. As studies are developed they should be designed to
include interactions between components of human milk
and complementary foods, including formula.
Intestinal Development The gastrointestinal (GI) tract
undergoes significant postnatal growth and functional adap-
tation in response to feeding (reviewed in [12, 19]). The
transition from predominantly parenteral support via the
umbilical cord to enteral support via human milk or formula
presents a challenge to the researcher who must come to
understand the interaction between GI mucosal surfaces and
environmental stimuli such as dietary antigens, commensal
and pathogenic microbiota and their products [20, 21]. In
addition, hormones and growth factors constitute a class of
bioactive proteins and peptides in milk [19], the best-studied
of which include insulin-like growth factor-1 (IGF-1), epi-
dermal growth factor (EGF), and transforming growth factor
(TGF)-β. Our current knowledge of the mechanisms by
which these and other bioactive components act in the
neonatal intestinal has been limited by the complexity of
human milk, an inadequte understanding of the normal
progression of postnatal intestinal development and its un-
derlying regulation, and the limited number of non-invasive
methods available to assess the impact of milk components.
Recently, Chapkin and colleagues used exfoliated epithelial
cells to assess intestinal gene expression, documenting dif-
ferences between cells from human milk- and formula-fed
infants [22]. This non-invasive research model along with
studies in neonatal pigs [23] and, potentially, monkeys [24]
provides an important system to understand the effects of
milk components on GI development.
A Note About Colostrum Colostrum is secreted by lactating
women in small quantities (~100 ml per day) for the first
2 days after birth, during which its composition is constantly
changing [25]. In species that, unlike the human, do not
transfer systemic immune components across the placenta,
the IgG in colostrum provides systemic immunity to the
offspring while their endogenous immune systems develop
[26]. Human colostrum has very little IgG and does not
directly provide systemic immunity, but does have high
concentrations of protective components such as secretory
immunoglobulin A (sIgA), lactoferrin and human milk oli-
gosaccharides (HMO) [27], which provide protection to
mucosal surfaces. Human colostrum also contains growth
factors and cytokines such as transforming growth factor
(TGF)-β, interleukin-(IL)-10, and erythropoietin that can
suppress inflammatory responses in the immature neonatal
intestine [12]. Detailed knowledge of the time course of
secretion of these colostrum components through lactation
as well as the mechanisms by which they act to promote
intestinal development is likely to lead to optimized proto-
cols for feeding human milk and/or its components to at-risk
infants (See Topic IV).
Protection Against Infection Because conferring resistance
to infection is a major function of human milk and is
critically important in developing countries, it is imperative
to understand which components of milk are most important
for this effect and their mechanisms of action. Many milk
proteins such as lactoferrin and lysozyme have direct anti-
microbial effects [28–30]. Others such as oligosaccharides
may act as decoy receptors to block adhesion of pathogens
to epithelial cell surfaces [31]. Human milk nucleotides
have been shown to stimulate an increased host immune
response [32, 33].
An improved understanding of antimicrobial components
in human milk may foster the development of resources to
improve the antimicrobial quality of animal milks. For ex-
ample, elevated lysozyme concentrations in the milk of
transgenic goats improved duodenal development and re-
duced the levels of inflammation and E.coli in the ileum of
neonatal pigs [34]. This experiment illustrates both the
potential of transgene-expressed protective substances in
animal milks and an elegant use of the piglet to study the
function of milk components.
Immune Development and Altered Allergic Responses Sys-
temic and mucosal immunity begin to develop in utero, and
continue to develop from the postnatal period through early
childhood. The neonatal mucosal immune system is rela-
tively devoid of IgA producing B cells. Secretory IgA
available through human milk may serve a compensatory
role as the infant’s IgA producing B cells develop and
differentiate following exposure to antigens ex-utero. Cues
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from the microenvironment including the gut microbiome
[35] and nutritional components regulate the development
of the immune response both locally in the intestine and
systemically. An important example is the observed role of
vitamin A metabolites acting via the retinoic acid receptor to
suppress development of Th17 cells [36]. Other molecules
in milk that have receptors expressed by cells of the immune
system include lactoferrin (lactoferrin receptor) [37] and
acidic sialic acid-containing carbohydrates that may poten-
tially bind to sialic acid binding receptors, also known as
SIGLECs [38]. Data from animal models suggest that aller-
gen exposure via human milk mediates development of
regulatory T cells in neonates that, in turn, protect the
animal from developing asthma when later challenged
with the allergen [39]. Whether these findings translate
to humans remains an important question given that the
incidence of childhood allergy continues to increase [40].
Studies of the immunological properties of humanmilk and
its effects upon the infant should provide important insights
into several issues:
1) Regulation of the development of the infant’s immune
system and inflammatory responses,
2) The optimal duration of breastfeeding
3) The role of milk in the future programming of
diseases mediated by infections, immunologic events or
inflammation.
Understanding of these issues would afford insight into
novel means to impact human health and development.
c. What is the role of human milk in establishing the infant
microbiome? (Contributors: Frank, Janoff)
The infant GI tract is immunologically and microbiologi-
cally naive at birth. The early days and weeks following birth
mark a period of profound change in the neonatal GI tract as
the number of bacteria increase from near-sterility to levels
found in adults [41, 42] (Fig. 2). Over the ensuing 12–
24 months, the GI microbiota transitions to domination by
obligate anaerobes of the phyla Bacteroidetes and Firmicutes.
In parallel with this microbial succession, the gut-associated
lymphoid tissue (GALT) and other components of the innate
and adaptive mucosal immune system reach maturity [13]. In
mice the presence of microbial communities in the gut is an
essential driver of GALT development [43, 44]. Analogously,
the human GI microbiome likely is a critical determinant of
infant immune function.
Both diet (breastfeeding vs. formula feeding) and mode
of delivery of the infant (vaginal vs. Caesarean) are signif-
icant early determinants of the kinds and quantities of
microbes that colonize the neonatal intestines [45]. For
example, Penders et. al. demonstrated that at 1 month of
age, the potentially “beneficial” Bifidobacteria strain was
more prevalent and present in higher numbers among 700
exclusively breastfed Dutch infants than in 232 formula-fed
infants and 98 infants who received mixed feeding [46]. In
contrast, microorganisms such as Clostridium difficile,
Bacteroides fragilis and E. coli that are believed to have a
higher inflammatory potential were present in higher numb-
ers in the latter group, as were Lactobacilli. Human milk
oligosaccharides are fermentable and selectively nourish the
growth of specific strains of Bifidobacteria found among the
microflora of the breastfed infant [14, 47]. Data from in
vitro studies suggest that proteolytic fragments of α-
lactalbumin, lactoferrin, and the secretory component of
the polyimmunoglobulin receptor (35) can selectively stimu-
late the growth of Bifidobacteria [48]. An important unknown
is the nature of other digestion products of milk proteins that
may play a role in specifying the infant microbiome.
Despite the great progress made recently in linking the GI
microbiome with nutrition, feeding practices and immunity,
many important questions remain unanswered:
1) How do the microbes that colonize the developing gut
program immune development?
2) Do perturbations of the GI microbiome resulting from
mode of feeding, delivery, or antibiotic exposure have
long term health consequences?
3) Can a dysfunctional neonatal microbiome be bioreme-
diated by dietary interventions?
Recently it has become clear that a complex microbiome
exists in human milk [49] although whether these microflora
contribute to the infant microbiome is not clear. Further, the
source of these microorganisms and the factors that influ-
ence their presence are completely unknown.
d. How do environmental agents and pharmaceuticals in
milk affect infant development? (Contributors: Badger,
Meier)
Research Target: Compile a complete database of
commonly used therapeutic drugs that includes
Fig. 2 Development of the microbiome in the human infant. Figure
modified from references 41 and 42
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their rate of secretion into milk as well as effects on
infant health and development.
In 2006 more than 1 million mothers in the US cited the
need to take a wide variety of medications as the reason they
elected not to breastfeed [50]. In addition mothers are un-
fortunately not immune to the effects of recreational drugs
and cigarette smoking. Recent articles indicate that codeine
and the nicotine derived from cigarette smoking [51] are
secreted into the milk with significant effects on the infant.
These effects, which can result in infant death [52], empha-
size the potential dangers of maternal drug use for the infant.
Likewise, beyond the established pronounced effects of
alcohol consumption on the unborn fetus, alcohol intake
by lactating mothers alters the sensory properties of human
milk and infant nursing behavior [53].
Many mothers have conditions that legitimately require
consistent drug therapy including psychiatric problems, heart
disease, hypertension and rheumatic illnesses. For rheumatic
diseases good recommendations about drugs that can and
cannot be used during pregnancy and lactation are available
[54]. There is considerable information about levels of anti-
depressants in maternal plasma and humanmilk, but very little
information exists about their effects on infant behavioral
outcomes [55]. Caregivers and potential breastfeeding moth-
ers must have appropriate information regarding the effects of
specific drugs on breast milk and on infant health in order to
make appropriate decisions about breastfeeding.
e. What is the role of dairy products in infant nutrition?
(Contributors: Williamson, German, Hovey)
The dairy industry currently embraces an emerging po-
tential for personalized nutrition and designer milks. These
concepts are intertwined. In the context of infant formula,
they translate to a design that is (1) humanized, (2) special-
ized for clinical use, (3) supplemented for optimized neona-
tal health.
Important questions for future consideration are:
1) To what extent can the functions of human milk com-
ponents be mimicked by the corresponding molecules
in milk from other species?
2) Can specific components of human milk be replaced by
non-homologous components?
3) Can molecules synthesized in yeast, fungi or plants, or
recombinant molecules, be used to supplement formula
with positive outcomes?
A good deal of current attention has focused on oligo-
saccharides as likely-important substrates for gut biota [14].
These molecules have been associated with resistance to
allergies and infections as they are thought to foster a robust
immune system. An important question for future research
is to what extent bovine milk oligosaccharides can support
“healthy” infant-type growth of Bifidobacteria. The need for
further research into the detailed composition of cow and
goat milks is important given that its synthesis and post-
harvest processing can provide for new, possibly designer
molecules that are able to enhance human health.
Topic II. Effects of Milk on Cognitive and Behavioral
Development
Research Target: Determine the effect of specific
and interacting components of milk on brain devel-
opment and the behavioral phenotype.
An important but poorly understood area is the effect of
mother’s-own milk on both cognitive development and the
behavioral phenotype. Optimizing cognitive development is
critical given that children with impaired cognition adapt
less well to stressful events, are more vulnerable to anxiety
and attention deficits and often require expensive special
education programs. In many parts of the world, including
the US, cognitive impairment contributes to the cycle of
poverty and disease [56, 57]. Moreover, cognitive dysfunc-
tion is a major co-morbidity in a number of neuropsychiatric
diseases that manifest later in life [58]. Understanding the
role of milk components in cognitive and behavioral devel-
opment is therefore a crucial area for research.
a. What are the components of milk that affect cognitive
development and how do they work? (Contributors:
Hinde, Donovan)
Human milk has relatively high concentrations of mole-
cules that foster brain development including choline, sialic
acid and long-chain polyunsaturated fatty acids (LC-PUFA)
[59]. Prenatal exposure to choline and its long-term effects
on hippocampal development, learning, memory and emo-
tional behavior have been studied extensively in animal
models [60], although relevant data for humans are lacking.
More recently, attention has been focused on sialic acid
(SA) given that accretion of SA-containing gangliosides in
brain increases nearly 3-fold from week 10 of gestation
through 5 years of age [61]. Likewise, an important role
for LC-PUFA in brain maturation has long been suspected;
these lipids, particularly docosahexaenoic acid (DHA) and
arachidonic acid (AA), are present in human milk at much
higher concentrations than in bovine milk and can be
altered by diets containing large amounts of fish oil
[59]. Although infant formula is often supplemented
with LC-PUFA [62], any long term effects of these compo-
nents on cognitive development have been difficult to docu-
ment in term infants [63].
Important studies by Caspi and colleagues showed that
the effects of breastfeeding on IQ can be mediated by
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genetic variation in FADS-2, a gene involved in desaturating
LC-PUFA [64]. Compared to infants with no mutation,
feeding human milk in infants who were homozygous for
this mutation increased their IQ at 6.5 years of age [65].
Another group found that mothers homozygous for the
mutation did not increase the proportion of LC-PUFA in
their milk with increasing fish and fish-oil intake [66]. The
implications of these findings for supplementation of moth-
ers and/or infants with LC-PUFA have yet to be established.
Importantly, however, these data clearly illustrate two major
points.
1) Gene-diet interactions exist that may affect both milk
composition and infant development.
2) Any effects of genetic polymorphisms on infant out-
comes may be masked when only mean values are
compared across populations. The ends of the bell-
shaped curve may give important information about
the contribution of specific gene-diet combinations.
b. What elements of breastfeeding affect behavioral phe-
notype? (Contributors: Hinde, Friedman)
Behavioral phenotype is defined as the observable “be-
havioral characteristics of an individual resulting from the
interaction of its genotype with the environment, often man-
ifested in a suite of co-varying behaviors” [67]. Feeding
mother’s-own milk reflects a complex physiological and
behavioral negotiation between the mother and the infant
that begins during pregnancy [68] when the mammary gland
develops functionally and is potentially sensitive to fetal
signals [69]. A number of components in milk subsequently
impart specific effects on development. For example, relax-
in in sow’s milk in the early post-partum period programs
uterine development [70] giving rise to what Bagnell termed
the “lactocrine hypothesis”. Behavioral interactions between
mothers and their infants during lactation can influence milk
removal and thereby alter milk synthesis [69]. But are
there lactocrine influences on the infant’s behavioral
trajectory?
Studies in the rhesus macaque strongly suggest that that
the answer to this question is “Yes”. Specifically, the cortisol
content of the mother’s milk was significantly related to
infant’s behavioral phenotype [71]. Further, Hinde and
Capitanio [71] demonstrated that milk energy density and
yield predict behavioral outcomes for both male and female
infants. Importantly, the observed temperament and behavior-
al outcomes reflected available milk energy from months
earlier, not at the time of assessment, suggesting that early
nutrition organizes, or programs, infant behavior during crit-
ical windows of development. In another setting a maternal
diet high in fat (HFD) perturbed the central serotonergic
system of offspring in monkeys leading female offspring from
HFD-fed mothers to exhibit increased anxiety in response to
threatening novel objects. These findings have important clin-
ical implications as they demonstrate that a maternal HFD
during gestation and lactation, independent of obesity, may
increase the risk of developing behavioral disorders, such as
anxiety, in the offspring [72].
A recent report from the Cambridge Baby Growth Study
suggested that breast- and mixed-fed human infants had
more labile temperaments than formula-fed infants [73]. Is
this a lactocrine effect of milk cortisol? The relationship
between maternal cortisol and infant temperament was ex-
amined in breast- and formula-fed infants [74]. At 2 months
postpartum breastfeeding mothers with higher plasma corti-
sol (used as a proxy for milk cortisol) rated their infants
significantly more fearful than did breastfeeding mothers
with lower plasma cortisol concentrations. Importantly, this
relation was absent when infants were formula-fed. These
data support the hypothesis that the cortisol ingested via
milk has a lactocrine effect on infant temperament.
c. Methods for studying the effects of milk on cognitive
and behavioral development (Contributors: Badger,
Donovan, Hinde, Friedman,)
Research Target: Understand the effects of mother’s
own milk and its components on the trajectory of
infant cognitive and behavioral development.
Studies in humans and animal models will be needed to
unlock the role that specific molecules and maternal behav-
iors play in early development in the neonate. When inves-
tigating potential lactocrine influences on infant behavioral
development a number of interacting factors must be con-
sidered as shown in Fig. 3. Focused attention needs to be
placed on subjects whose developmental trajectories deviate
significantly from the norm. In such a population it is often
possible to identify specific, genetic or environmental fac-
tors that impact infant development. Examining the sources
of variation (environmental, psychological, physiological,
Fig. 3 Interactions of components influencing the behavioral pheno-
type. Adapted from reference 68
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metabolic, dietary, lifestyle, social) and the consequences of
that variation for the infant (immune, neurobiological, phys-
ical, and behavioral growth/development) will allow us to
promote better breastfeeding practices while improving for-
mulas for vulnerable populations.
Studies in Human Mother-Infant Pairs Specific testing of
brain function, especially within the first year of life, has
provided mixed, albeit variable, results with respect to a
comparison between breastfeeding and formula. An elegant
technique known as event-related potentials (ERP) can be
used to measure infant responses to stimuli that are potential
important in language acquisition. However, experiments
using this technique have yielded mixed results with respect
to differences between formula- and breastfed infants
[75–77]. The caveat is that all of these ERP studies were
conducted at a single age; infants develop rapidly in the first
few months of life and acquire processing abilities at slight-
ly different ages, so these differences could reflect the indi-
vidual developmental trajectories. None-the-less these
studies indicate that sophisticated cognitive tests are avail-
able to test hypotheses about behavior-modifying effects of
specific milk components. It is important to take into ac-
count factors such as parent education, IQ, socio-economic
status, maternal-infant interactions, and home environment
if these studies are to provide reliable information about the
effects of milk components.
Studies in Non-Human Primates Compared to the altricial
young of rodents, primate infants begin to engage behavior-
ally with a wide social network including parents, siblings,
friends, and other conspecifics soon after birth. Infants de-
pend on mother’s own milk, or an alternative, not only for
nutrition but to sustain these social interactions during the
post-natal period. Careful studies in primate populations
relating variations in milk composition and volume among
individual mothers to their nutrition, health, body mass,
social condition may identify lasting consequences for neu-
rodevelopment and behavior. Importantly, among primates
the early expansion of an primate infant’s behavioral reper-
toire is co-incident with critical windows of neurodevelop-
ment [78].
A better understanding of the neurobiological underpin-
nings of behavioral outcomes is needed to extend these
findings for translation to human health. Although non-
human primates are likely the most similar to humans for
investigating how milk influences neuro-psycho-biological
development and social behavior, additional animal models
particularly pigs and rodents will provide crucial, comple-
mentary information. The dairy science literature may also
be a source of important information given that milk pro-
duction is closely linked to the behavior of the cow during
milking [79].
Topic III: Maternal Factors Affecting Milk Volume
and Composition
Hormones coordinate mammary gland development and
lactation with reproductive development and needs of the
infant (Fig. 1) [80]. During early pregnancy, for example,
ovarian progesterone and pituitary prolactin initiate and
promote alveolar proliferation. As pregnancy progresses
placental hormones play significant but poorly understood
roles in promoting alveolar differentiation. The abrupt fall in
progesterone at parturition fosters secretory activation
which depends on prolactin and, as recently elucidated,
insulin [81]. Infant suckling promotes the secretion of both
prolactin and oxytocin. Although cortisol has long been
considered essential for mammary differentiation [82], its
mechanism of action is poorly understood. While recent
work has been carried out in mice and earlier work stemmed
from research on animals including goats, sheep, cows, rats,
rabbits and sows [83, 84], it is unclear to what extent the
mechanisms defined in these studies apply to women. Fur-
ther, the influence of substrate availability on milk secretion
and composition [85] as well as the effects of lactation on
systemic metabolism have been widely documented in cows
[86], although few studies of the interactions between lac-
tation and systemic metabolism exist in other species. In this
section we focus on several issues that are likely to be
increasingly important as we seek to produce sufficient
human milk of appropriate composition for complete suste-
nance of infants for 4 to 6 months and partial sustenance
thereafter.
a. How do hormones and metabolism coordinately pro-
gram the mammary gland for lactation? (Nommsen-
Rivers, Neville, Hinde)
Research Target: A mechanistic understanding
of the factors and signaling pathways that regu-
late mammary differentiation in late pregnancy,
at parturition and during lactation.
A number of irreversible switches govern mammary
gland development: The first is the increase in circulating
estrogen at puberty that switches on ductal growth. The
hormones of pregnancy, progesterone and prolactin, switch
on alveolar development. At mid-pregnancy another switch
(secretory differentiation, previously called lactogenesis I)
leads to a decrease in proliferation and brings about differ-
entiation of mammary epithelial cells such that they can
produce milk during the subsequent lactation. At parturition
a fall in progesterone switches on milk secretion (secretory
activation, previously called lactogenesis II). Cessation of
milk removal at weaning brings about the last switch that
induces glandular involution. We have little understanding
of the mechanisms by which epigenetic modifications in
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signaling pathways and gene expression might activate and
regulate these switches [87].
The roles of estrogen, progesterone, EGF and related
ligands, and prolactin, the receptors for these ligands, and
their downstream signaling molecules appear to be well
understood [80]. However, modern investigations of regu-
latory mechanisms in vivo during late pregnancy, at partu-
rition and during lactation, mostly in mice, have been
hampered by the problem that the loss of specific growth
factors or signaling systems results in an early block of
mammary gland development with a total loss of secretory
activation and lactation. Further, we do not understand the
relevance and application of these mechanistic data derived
largely from studies in mice.
While we know how prolactin affects the synthesis of
many milk components [88], the signaling pathways and
downstream targets for insulin, glucocorticoids and proges-
terone are less well understood. These hormones are active
either in late pregnancy or in lactation, when systemic
metabolic factors may also influence their activity. Similarly
while the effects of estrogen on ductal development are
reasonably well understood, many environmental agents
have estrogenic activity, meaning it is important to under-
stand precisely how estrogens modify mammary gland de-
velopment and lactational competency. We summarize the
roles of insulin, glucocorticoids and progesterone here and
discuss estrogens in the context of their environmental
presence.
Insulin Insulin has long been used in culture models of
mammary differentiation [82], although the high concentra-
tions likely acted through the IGF1 receptor. Strong evi-
dence now emphasizes that insulin signals through the
insulin receptor during lactation [81, 89]. If this is also true
of the mammary gland during pregnancy, then the effects of
insulin upon epithelial differentiation could substantially
influence breastfeeding success. Hypoinsulinemia, as can
occur temporarily in Type I diabetes, might interfere with
differentiation. The hyperinsulinemia that occurs during
obesity and gestational diabetes could hyperstimulate insu-
lin signaling perhaps promoting premature initiation of lac-
tation with subsequent premature involution, since secreted
milk could not be removed from the gland. Overexpression
of activated Akt, a downstream mediator of insulin signaling
had exactly this effect in the mouse mammary gland [90].
Animal studies, possibly in genetically altered mice or larger
species more similar to humans such as pigs, along with
human studies correlating insulin levels in pregnancy with
lactation performance will be necessary to test this
hypothesis.
Glucocorticoids Although glucocorticoids have long been
considered important for milk synthesis [82], they are also
associated with the suppression of milk synthesis and milk
letdown under stressful situations [91]. The complex effects
of glucocorticoid action on lactation are illustrated by the
observation that betamethasone, a glucorticoid, facilitates
milk production by mothers of preterm infants if given
antenatally within 2 days of birth, but inhibits milk produc-
tion when given 3 to 9 days prepartum [92]. In a mouse
model of deficient glucocorticoid secretion, both pup
growth and the expression of milk proteins were compro-
mised [93] highlighting a clear requirement for corticoids
for proper lactation.
An important question is the role of acute or chronic
stress on glucocorticoid signaling. Non-human primate
models will be valuable for future research, given their
translational potential for humans. Rhesus macaques pro-
duce singletons, like humans, and show substantial individ-
ual variation in milk cortisol concentrations [94].
Marmosets (Callithrix jacchus), a smaller neotropical mon-
key more distantly related to humans, are emerging as a
valuable model of obesity and reproduction [95] and could
be particularly useful for understanding metabolic disease
and lactational performance.
Progesterone While the proliferative effects of progesterone
on alveolar development in early pregnancy have received
considerable attention [96] the mechanism by which pro-
gesterone represses secretory activation in late pregnancy
has been difficult to study because of the paucity of in vitro
model systems for mammary differentiation and the com-
plexity of progesterone and prolactin receptor interactions
[97]. New in vitro model systems in which mammary dif-
ferentiation can be studied [96, 98], coupled with studies of
animals with mutated receptors or downstream effectors are
an important next step in elucidating this aspect of proges-
terone action.
b. What are the genetic and epigenetic elements that
affect heritability of mammary gland development
and lactation-related traits? (Contributors: Hadsell,
Rijnkels)
Research Target: Identify the genetic and epigenetic
basis for heritable maternal traits related to lactation
success.
Two modes of inherited traits are now recognized: (1)
Traits based on DNA sequence are passed genetically to the
offspring. (2) Epigenetic alterations in DNA including DNA
methylation or other mechanisms can also be passed to the
offspring [7]. The relevance of each for human lactation is
discussed below.
Genetic Traits Mammary development and lactation reflect
a collection of quantitative traits that have a continuously
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distributed variation. It has been clear for nearly a century
that variation in these traits cannot be fully understood
without studying both genetic and environmental factors
[99]. Studies in dairy animals show that genetics can ac-
count for as much as 40 % of the variation in lactation-
related traits [100]. Litter weight gain in mice, which is an
indicator of lactation success, is also heritable with genetics
accounting for as much as 33 % of the observed variation
[101]. In addition, milk production by dairy animals and
rodents can be increased through genetic selection [102,
103]. In parallel, natural genetic variants in humans that
alter mammary gland development or produce inadequate
lactation are known. For example, isolated prolactin defi-
ciency in women is an autosomal recessive trait known to
produce a lactation defect [104]. Finlay-Marks syndrome,
thought to involve mutations in the Lef1 gene, is an inherited
condition that results in the absence of pregnancy-dependent
breast development [105]. Mutations in the gene SLC30A2
that specifies a zinc transporter in the mammary gland
have been documented to result in milk with low zinc
concentrations [106, 107]. A genetic variation in FADS2
leading to altered fatty acid profiles in human milk was
discussed in Topic II [66]. Despite these examples, our
understanding of the role of natural genetic variation in
determining mammary gland development and lactation in
humans and species other than dairy animals is very
limited. Work in mice has led to the identification of
lactation quantitative trait loci [108] although the specific
genomic loci have yet to be established. Lactation success
in humans varies by race or ethnicity [109] although again
the specific genetic differences are not known.
In the 11 years since the publication of the human
genome enormous advances have been made in cataloging
the variation that exists both in humans [110] and in
animal models such as the mouse [111, 112]. These
resources have already been applied to other aspects of
human health and disease. A concerted effort is needed to
employ these genomic resources toward understanding
mammary gland development and lactation in humans
and animal models.
Epigenetic Changes An interesting question is whether
programming of mammary cells occurs in utero or during
lactation in response to maternal nutritional status or other
maternal factors. This programming might potentially affect
the development and/or lactation performance of the off-
spring resulting in epigenetic inheritance of lactation traits.
Maternal nutrition during pregnancy and lactation can affect
the susceptibility of female offspring to mammary tumori-
genesis in animals [113, 114]. The nutritional status of
gestating sheep produced heritable effects on lactation suc-
cess in two generations of female offspring [115, 116]. Are
such inherited epigenetic changes in mammary development
a cause of lactation difficulties in obese women? The answer
to this question is particularly important as we seek to
reduce the consequences of the obesity epidemic.
c. What are the mechanisms by which maternal nutrition,
disease, and metabolic status affect milk composition
and volume? (Contributors: Anderson, Friedman,
MacLean, McManaman, Van Houten)
Research Target: Carefully controlled studies in
humans and relevant animal models to dissect the
effects of nutrition, maternal adiposity, and meta-
bolic disease on lactation performance.
Maternal obesity in humans increases the risk of unsuc-
cessful initiation of breastfeeding and impaired ability to
sustain lactation once initiated [117, 118]. A similar lacta-
tion impairment with obesity was observed in mice fed a
“Western” diet, where obese dams produced lipid-poor milk
that attenuated litter growth, compared to litters of lean
dams on this same diet [9]. As an endocrine disorder obesity
has the potential to impact breastfeeding and lactation at
several levels including impaired hormonal regulation of
mammary gland development [119], altered synthetic and
secretory function [9, 120] and disrupted neonatal appetite
control mechanisms [121], all impacting higher order inte-
gration of infant feeding needs with milk production and
ejection [119]. We also need to understand whether the
mammary adipose tissue produces locally effective concen-
trations of estrogen in obese women that could alter mam-
mary gland development and lactation.
Animal models such as rodents (for gene targeting stud-
ies) and pigs (for nutrition and endocrine studies) as well as
new quantitative approaches in humans that take the mother-
child unit into account as an integrated physiological unit
need to be developed. The opportunity also exists to incor-
porate findings from several decades of research on dairy
animals into these investigations.
d. What breastfeeding practices prevent inadequate lacta-
tion performance? (Contributors: Morrow, Nommsen-
Rivers, Meier, Bunik)
Research Target: A fundamental understanding of
the biological and psychosocial causes of inadequate
lactation performance including delayed onset of
lactation and consistent low milk production. Also
the effect of low milk production during weaning on
the composition of milk.
Inadequate lactation performance may reflect deficien-
cies in mammary gland development and initiation of lacta-
tion as well as ineffective milk removal from the breast by
the infant. The mechanisms underlying delayed onset of
lactation, lactation failure, and low milk production are
J Mammary Gland Biol Neoplasia (2012) 17:167–188 177
poorly defined in part because such deficiencies are rarely
investigated due to the ready availability of formula.
Mothers of preterm infants [92], obese women, and
women with diabetes and other diseases find initiating and
sustaining milk production to be difficult [117]. It is known
that stress during labor delays the initiation of lactation
[122] and epidural anesthesia during labor interferes with
milk letdown [123]. As stated earlier, cortisol given during
impending preterm labor affects milk production in variable
ways depending on the time elapsed between injection and
birth of the infant [92]. Do these observations reflect
changes in the initiation of lactation or the ability to produce
adequate milk having an appropriate composition? Few
studies have been designed to differentiate between these
two alternatives, which undoubtedly have different mecha-
nistic bases.
Research on the role of maternal obesity and the effects
of stress in lactation performance are priority areas. In both
cases it is likely that an altered maternal endocrine environ-
ment and possibly proinflammatory cytokines are at least
partially responsible for lactation impairment. In the case of
obesity the roles for insulin and prolactin [124] require
detailed investigation. A pumping regimen for breast milk
expression [125] should be tested in prospective studies to
determine whether a regimen like that used for mothers of
preterm infants can improve milk production. Along with
studies of such an intervention, ultrasound or MRI measure-
ments of active breast tissue coupled with plasma levels of
relevant hormones and proinflammatory cytokines would
lay the groundwork for understanding the biological basis
of these problems.
Milk Production in the Presence of Complementary
Feeding A question which often arises is “what is the effect
of complementary foods on milk production and composi-
tion”. In a 1991 study [25] milk production fell as mothers
decreased the number of daily feeds and milk volume was
less than 100 ml per day when daily feeds were fewer than
two per day. More importantly, at milk volumes below
200 ml per day, significant increases in the concentrations
of protein, sodium and potassium and a decrease in lactose
concentration were observed. An important question is
whether the protein and carbohydrate composition in the
presence of low milk volumes is altered in such a way that
the concentration of protective substances like lactoferrin,
lysozyme, IgA, and oligosaccharides is increased. If so,
continuation of breastfeeding as long as possible after intro-
duction of complementary foods may be important for pop-
ulations in developing countries.
The Role of the Infant in Milk Production Milk removal has
long been known to be a major factor in determining the
amount of milk secreted by both humans and animals [80].
Infants with ineffective and/or inefficient sucking patterns
do not provide the physical breast stimulation and milk
removal needed for continued milk synthesis. Thus, ineffec-
tive suck can be a key element in lactation failure in both
humans [126] and animals [127].
Infant suck is adversely affected by infant morbidity and
prematurity [128]. Late preterm infants are at particularly high
risk [129] since these infants are often cared for in the general
maternity setting where breastfeeding is managed according
to guidelines for healthy term infants. Maternal medication
and drug use [130] and infant ankyloglossia [131] are also
believed to contribute to ineffective infant suck. A systematic
research approach is necessary to define elements of lactation
failure related to these problems in the infant.
e. How do environmental agents and pharmaceuticals affect
milk volume and composition? (Contributors: Badger,
Hovey, Horseman)
Research Target: Determine the effects and long-
term implications of drugs, hormones or phyto-
chemicals (especially dietary factors) on lactation.
The developing mammary gland is affected by a variety of
environmental factors including xenobiotics such as phyto-
chemicals present in common fruits and vegetables [132,
133]. Semi-purified or processed whey proteins used in infant
formulas can have similar effects [134, 135]. Although this
research area is relatively new, it is now clear that such sub-
stances, whether in medications or in the diet, can act through
signaling pathways that regulate mammary development. For
example, feeding diets rich in soy or whey proteins can have
effects similar to those induced by estrogen [136, 137]. Fur-
thermore, there is widespread use of herbal agents, phyto-
chemicals, off-label pharmaceuticals, and even alcohol by
women who have a real or perceived difficulty to lactate, yet
the full consequences of these agents are unknown.
Numerous environmental factors likely affect initiation of
lactation or milk secretion; most significant among these are
pharmaceutical agents taken by the mother. For example, in
one study of women initiating breastfeeding the use of
SSRI’s (selective serotonin reuptake inhibitors, psychotro-
pic drugs) resulted in a substantial delay in the onset of
lactation [138]. No mothers using an SSRI initiated lactation
before 72 h postpartum. Drugs can also impair milk ejec-
tion, diminish milk volume, and alter milk composition.
Animals can be very useful for studying the mechanisms
of these effects; for example it has been found that dopami-
nergic agonists inhibit prolactin release in dairy cows [139]
and beagles [140]. Although the effects of many of these
compounds on breast cancer have received considerable
research attention, studies of their effects on lactation are
poorly represented in current research agendas.
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Topic IV: Breastfeeding and the At-Risk Neonate
For the purposes of this review at-risk populations include,
but are not limited to, low-birth weight/preterm infants,
offspring born to obese women or women with diabetes
during pregnancy, and infants born in low-resource settings
characterized by chronic disease and pandemic infection,
food insecurity and poor sanitation. Because the benefits
of human milk are likely to be magnified in these groups
and settings, such studies are likely to provide opportunities
to improve our understanding of mechanisms involved in
the effects of milk constituents on infant health and devel-
opment. Such studies should also clarify the importance of
utilizing human milk or substitutes in these populations as
well as the nature of effective substitutes.
a. What is the role of human milk in the nutrition of the
preterm infant? (Contributors: Meier, Neu).
Research target: A comprehensive understand-
ing of the components of human milk responsi-
ble for reducing the risk of morbidities for
preterm infants, the mechanisms by which they
act, and how they are affected by common
NICU practices for collecting, storing, handling
and feeding human milk.
Many organ systems are immature in preterm infants,
particularly those who are born very low birth weight
(VLBW; <1,500 g birth weight) and extremely low birth
weight (ELBW; <1,000 g birth weight). These infants have
substantially diminished stores of micro- and macronutrients
that are ordinarily deposited during the last trimester in
utero. These stores are rapidly depleted after birth due to
the co-existence of morbidities that compound the difficult
problems already associated with the nutrition of these very
small infants. Immediately after birth, ELBW and VLBW
infants receive parenteral nutrition with small volumes of
enteral nutrition that are introduced and advanced as toler-
ated by the infant. However, even if full enteral nutrition is
achieved, human milk does not meet the micro- and macro-
nutrient requirements of these infants because of their high
nutrient demands and the limited milk volumes they can
safely ingest. Thus, commercial fortifiers and other exoge-
nous supplements must be added to human milk to provide
additional nutrients for ELBW and VLBW infants.
The fact that adequate early nutrition in the smallest
preterm infants is subsequently linked to better neurodeve-
lopmental outcomes, highlights the importance of prevent-
ing, recognizing and correcting nutrient deficits soon after
birth. However, evidence-based strategies for doing so are
limited. Feeding human milk to these infants does reduce
the risk of serious and costly neonatal intensive care unit
(NICU)-acquired morbidities such as NEC and late onset
sepsis. Human milk also promotes intestinal [12], cognitive
[141] and immune [142] development. An important mech-
anistic element may be the development of an appropriate
intestinal microbiome [143]. There may also be critical
periods during the NICU hospitalization when human milk
is most important–delineating these periods remains a pri-
ority for research [144] as does the practical matter of
collecting, storing, handling and feeding human milk.
As emphasized in section I, while a clear understanding
of how milk components exert their effects is crucial, it is
also imperative to understand the within- and between-
mother variation in these components, and to determine
the mechanisms underlying this variation. Potential influen-
ces include duration of gestation as well as genetic and
dietary factors. Defining the temporal changes in human
milk composition is critical for the design of regimens for
feeding human milk to the premature infant in the NICU
where expressed milk is seldom fed in any particular order
[145]. While certain types of studies (for example, defining
the microbiota) can be done using preterm infants as an
experimental model, for many studies an animal model is
required. Here a role for the neonatal pig is assuming greater
importance [31, 146].
Because it is often difficult to obtain sufficient quantities
of human milk from mothers of preterm infants, we also
need to understand how to optimize milk synthesis and
removal in these mothers, most of whom are breast pump-
dependent for weeks or months. Mothers of preterm infants
have documented risk factors for delayed onset of lactation
and low milk volume, but the mechanisms underlying these
problems as well as their diagnosis and management are
poorly understood. Because preterm infants benefit from
even small enteral feedings as soon as they are able to
tolerate them, donor human milk is frequently recommen-
ded. However, many questions remain about the use of
donor human milk including which infants should receive
it, for how long, and where a source of suitable donors can
be created [147].
Finally, a risk-benefit assessment model for the use of
therapeutic drugs for maternal diseases is critical. A useful
model would allow caregivers to balance the effects of
giving human milk vs formula against the potential negative
effects of drug therapy essential for maternal health on both
milk secretion and infant development.
b. What is the role of breastfeeding in preventing obesity
in susceptible populations? (Contributors: Dabelea,
Crume, MacLean, Friedman)
Research target: Understanding the mecha-
nisms by which breastfeeding modifies the fetal
programming of infants at risk for metabolic
disease as adults.
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Infants with intrauterine growth retardation as well as those
born to obese mothers, to mothers with gestational diabetes,
and to those who are malnourished are more susceptible to
developing the metabolic syndrome later in life, including
type II diabetes and heart disease [148, 149]. The extensive
literature on fetal programming for metabolic disease will not
be reviewed here. The important consideration is the role of
breastfeeding in abrogating undesirable fetal programming.
The Effect of Breastfeeding in the General Pediatric Pop-
ulation Studies assessing the influence of breastfeeding on
the risk of childhood overweight or obesity have demon-
strated significant protection [150], but the effect of breast-
feeding has been smaller and more variable when the
outcome is assessed as a difference in mean BMI. These
findings led some researchers to conclude that the effect of
breastfeeding is small and influenced by bias and confound-
ing. Importantly, in a recent study [151] school entry data on
14,412 children aged 4.5–7 years in southern Germany were
broken down by BMI percentile. After adjusting for a large
number of potential confounding variables, mean BMI was
significantly reduced in children above the 90th BMI
percentile who had been breastfed versus the formula-
fed children in this BMI group. Interestingly, among
children in the lower BMI percentiles (≥30 %), breast-
feeding was associated with a low but significant shift
towards a higher BMI. These results suggest that breast-
feeding prevents overweight and obesity in children
with a tendency to these outcomes, but does not affect
underweight children in terms of weight reduction. In a
very recent study of growth trajectories for offspring of
non-diabetic pregnancies slower growth velocity was
observed in those infants who were breastfed [152].
The effects of prior breastfeeding were particularly sig-
nificant at ages 6 to 13 years. Importantly the popula-
tion in this study was mostly middle class; extending
this type of research to lower socioeconomic groups
where obesity tends to be more prevalent is critical.
The Effect of Breastfeeding in the Children Exposed to
Maternal Diabetes and Obesity The potential of breastfeed-
ing to reduce the risk for obesity following in utero exposure
to overnutrition from a diabetic pregnancy or maternal obe-
sity has great public health significance. Among Pima Indi-
an youth exposed to maternal Type 2 Diabetes or gestational
diabetes those who were breastfed for at least 2 months had
a lower risk for developing diabetes compared to those who
were formula- fed (30.1 vs. 43.6 % risk) [153]. In a recent
comparison [154] of middle class children exposed to ma-
ternal diabetes in utero a significant decrease in childhood
BMI and central adiposity was observed among children
who were breastfed according current recommendations. A
similar (25 %) reduction in childhood obesity risk was
associated with exclusive breastfeeding for 6 months com-
pared to exclusive formula feeding [155]. Children who
received a mix of formula and human milk had results
similar to the formula-fed group. Similar results were
reported from 2 to 14 year old children in the National
Longitudinal Survey of Youth [156]. All these results are
consistent with the conclusion that children at risk for
childhood obesity stemming from exposures in utero benefit
significantly from breastfeeding.
Potential Mechanisms The increasing number of observa-
tions that breastfeeding alters the growth trajectory of off-
spring born from both diabetic and non-diabetic pregnancies
suggests that early infant diet has an important long-term
effect [157]. Understanding the mechanism of these effects
is important in determining what potential interventions might
be effective. The complexity of the issue is revealed by both
human and animal studies. For example, a quantitative rela-
tionship between consumption of milk from diabetic mothers
and the risk of overweight at 1–5 years of age has been
observed [157] suggesting an effect of diabetes on milk com-
position. When neonatal rats born to lean dams were cross-
fostered to obese dams they developed an obese phenotype,
including insulin resistance [158]. Maternal obesity in mice
was shown to alter milk lipid content leading to decreased
neonatal energy intake and decreased weight gain [9].
The question becomes What is the mechanism? Human
milk contains more lactose, specific fats and cholesterol and
relatively lower protein and mineral contents compared to
milk from other animals. It is also possible that specific micro-
nutrients or hydrolysates of macronutrients present in human
but not cow’s milk stimulate GI hormones that act on the
hypothalamus to regulate appetite. In support of this notion,
babies who were given cow’s milk formula with added gluta-
mate or hydrolyzed formula consumed fewer calories than
those who drank regular cow’s-milk formula [159]. The in-
fluence of the neonatal microbiome on development of appe-
tite regulation has been hinted at in rodent studies, but the
mechanism is poorly understood. An answer to the question of
whether satiety hormones such as leptin, adiponectin, and
ghrelin or pro/anti-inflammation components of human milk
have effects on infant adiposity, appetite, and energy expen-
diture could go a long way toward defining the early-life risk
factors that subsequently lead to adiposity.
In summary, breastfeeding may be a powerful strategy to
decrease the risk of obesity among offspring of mothers with
pregnancy-associated diabetes or obesity during pregnancy.
Additional research is needed to confirm this finding, to
define compositional differences in human milk from
healthy and diabetic mothers, to assess the influence of
combination feeding with formula and to find the mecha-
nism(s) involved. In addition, if breast-feeding has a signif-
icant effect on childhood obesity, principally for infants
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born to obese mothers, it will be important to find ways to
increase the rate of breastfeeding in this population, partic-
ularly given significant evidence that obese women have
problems initiating and maintaining lactation [117].
c. What is the role of human milk in preventing growth
stunting? (Contributors: Hambidge, Krebs)
Research Target: To develop nutritional pro-
grams that will prevent/ameliorate growth
stunting of malnourished infants.
Growth stunting is a serious problem in developing
countries where it is associated with poor cognitive and
educational performance [57]. This condition, if not
addressed prior to the third year of life has deleterious
effects on height, strength and intellect in adult life, re-
ducing what Vitora has called “human capital” [8]. The
problem is that while breastfeeding is associated with
improved survival in this population, it does not prevent
stunting.
Progress has been made toward increasing the rates of
exclusive breastfeeding for approximately the first 6 months
of life in low resource settings and is predicted to have a
major impact on infant survival (1). However, recent obser-
vations have highlighted faltering of very early postnatal
linear growth occurring even during the period of exclusive
breastfeeding [160]. Contrary to expectations, in most
instances the rate of energy intake is not the growth-
limiting factor. A possible causal effect on early growth
faltering is micronutrient inadequacy in milk from under-
nourished mothers particularly on the heels of micronutrient
deficiencies acquired by the fetus. Other possible explana-
tions include deleterious bioactive compounds in human
milk as a result of a pro-inflammatory environment due to
maternal metabolic dysregulation. Additional or alternative
factors in the intra-uterine or pre-conceptional environment
may contribute to altered infant growth patterns [161].
However, all these possibilities are poorly defined.
After approximately the first 4 to 6 months of near
exclusive breastfeeding the infant becomes dependent on
other sources to meet its requirements for iron and zinc.
These requirements are predictable due to depletion of in-
fant iron stores by this time and the physiologic decline in
zinc concentrations in human milk, respectively [162].
Broadly speaking, appropriate options are complementary
foods, fortified foods, or supplements [163]. Meat provides
both iron and zinc in a bioavailable form. Alternatively,
fortified cereal can be an acceptable and efficacious vehicle,
although the enteric microbiome and inflammatory responses
appear to differ from those achieved on meat diets. In sum,
research in this area has not yet found solutions to the problem
of appropriate complementary foods in the undernourished
population [164].
These observations illustrate the complexity underlying
perturbed infant growth patterns in disadvantaged popula-
tions, with likely interplay among nutritional, immunosti-
mulatory, and metabolic factors. The choice of interventions
must take into account infant nutritional status as well as the
nutritional and metabolic status of the mother. Better data
that improve our ability to make rational nutritional choices
for the undernourished infant will have a profound global
impact on long term health.
d. A community approach to lactation studies in at-risk
human populations. (Contributor: Seewaldt)
Research Target: Conduct meaningful clinical
studies in at-risk populations who may have
low socioeconomic status, poor health, poor nu-
trition and a myriad of problems that prevent
consistent access and participation.
As stated above, studies in at-risk populations are more
likely to yield statistically meaningful results about the
benefits of breastfeeding. However, these populations are
often difficult to access in a consequential way, particularly
for studies with a longitudinal component.
One particularly effective approach has been developed
for studying young women in a community that as a whole
is at high-risk for triple-negative breast cancer [165]. A
longitudinal study of breast cancer initiation in this popula-
tion was made possible by partnering with community
advocates and navigators. Key components of the partner-
ship included
1) Support for high-quality free breast cancer screening at
community clinics
2) Partnership with breast and cervical cancer control
programs
3) Free or low cost follow-up and treatment services
4) Community navigators
5) Mentorship of minority scholars.
Taken together, these components, as well as a willing-
ness to partner and listen, are essential for collaborating to
develop community-partnered studies.
Importantly, breastfeeding rates in this underserved popu-
lation are low and, for those women who do choose to breast-
feed, duration is short with many discontinuing within days
after birth [166]. Factors that are hypothesized to influence
breastfeeding incidence in this population include aggressive
marketing of humanmilk substitutes, workplaces that discour-
age breastfeeding, social and personal networks and cultural
norms, and individual beliefs about breastfeeding [166]. How-
ever, in some populations biological deficiencies in mammary
development may underlie lack of successful breastfeeding.
Effective studies of this problem will require a community
partnership like that developed for the study of breast cancer.
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V. Training the Future Lactation Biologist (Contributor: Shur)
Educational Target: New programs and resources to
repopulate the diminishing pool of lactation biolo-
gists and promote communication between the di-
verse disciplines required to understand milk, its
secretion and its effects on the neonate.
The pool of highly-trained investigators qualified to
study problems in lactation biology has been diminished
due to a variety of factors. Historically, many land grant
colleges had formal departments and training programs in
dairy and animal sciences, often funded by the USDA.
Because milk production worldwide now exceeds demand
and formula is widely available, revenue for studies of
lactation biology has decreased dramatically. The result
has been the reduction, if not closure, of some of these
departments, and a concomitant disappearance of training
programs in lactation biology. Further, support from federal
funding agencies such as NIH is often targeted toward
disease rather than studies of normal biology. In the
field of mammary gland biology and lactation the ma-
jority of this support is directed toward breast cancer
rather than lactation biology. In addition a lack of
formal clinical training in lactation biology in medical
school curricula coupled with the cancer orientation of
conferences and other traditional venues means that
there are few places where scientists in all disciplines
that now require knowledge of lactation biology can
exchange information and ideas. Therefore, we need
to implement new programs and resources to repop-
ulate the diminishing pool of lactation biologists. In
particular, federal funding agencies must make a con-
scious commitment to set aside resources to rebuild this
cadre of investigators through new training programs,
workshops, conferences, travel grants, and similar ini-
tiatives as described below.
a. Compelling reasons to pursue training in lactation
biology.
With a better appreciation of the benefits of breastfeeding
relative to formula, there has been a renewed interest in the
basic biology of lactation. In addition federal funding agen-
cies are now using their limited resources to focus on prob-
lems that directly impact human health including disease
prevention, for which the basic biology of the mammary
gland is a prime example. Furthermore, a fundamental un-
derstanding of lactation biology impacts a wide range of
disciplines, ranging from development, to biochemistry of
lipid and complex carbohydrates, to cell biology, to physi-
ology, to behavior, to clinical medicine. This understanding
is well- suited to the widespread new emphasis on multidis-
ciplinary “team” approaches to complex scientific problems.
There is also an emerging paradigm shift that animal models
no longer should be exclusively limited to rodents. Indeed,
the study of lactation is unique in that it is a process
common to all mammals, meaning there are certainly unex-
plored opportunities to address many of the above-
mentioned research targets in species besides rodents. This
approach will however require future scientists to be trained
in a variety of animal models.
b. Skills required of the next generation of investigators.
In this climate of limited resources, predoctoral training
programs should focus on the basic biomedical foundations
relevant to studies of lactation biology, rather than exist as
specialized training programs in this multifaceted discipline.
Predoctoral students interested in lactation biology should
receive training in endocrinology and integrative physiology,
nutrition, biochemistry, cell biology, molecular biology, innate
immunity, complex carbohydrates, bioinformatics, genetics,
and other relevant disciplines. For broader application to
breastfeeding it may be useful for students to be trained in
research approaches to human development, behavioral psy-
chology, sociology, public health and epidemiology.
c. Training the next generation of investigators.
Postdoctoral Training Programs Unlike predoctoral training
programs, postdoctoral training programs are an ideal venue
for specialized training in lactation biology, at which time
trainees should be exposed to the non-biomedical, psycho-
social aspects of lactation. Examples include the impact of
maternal behavior and stress on the quality of lactation, as
well as issues pertaining to health disparities that impact the
frequency and quality of lactation. In this regard, federal
agencies should set aside resources to provide training for
postdoctoral fellows, via both individual and institutional
training programs. Federal agencies should encourage cross-
institutional and cross disciplinary collaborations that bring
together experts representing the broad range of disciplines
and species relevant to studies in lactation biology. These
groups should include both basic and clinical investigators
and provide interactions with experts in the psychosocial
aspects of breastfeeding and the problems of providing
adequate nutrition for at-risk infants.
Focused Courses and Workshops Funds need to be made
available for “hands-on” workshops in order for postdoctor-
al fellows and new investigators to receive state-of-the-art
training. An intensive hands-on program could be modeled
after those offered at Woods Hole in Physiology, among
other disciplines. Such workshops could include basic tech-
niques in lactation biology, overviews of clinical lactation
topics, comparative model systems, compositional analysis
and, bioinformatics. Ideally such a meeting might best take
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place at a site that could offer complementary perspectives
from both dairy science and medical science. In this regard,
funds need to be made available to support the travel and
registration for trainees and new investigators in order to
participate in these programs.
Venues for Sharing Ideas/Resources Trainees interested in
lactation biology need a “safe haven” to share ideas, their
work, problems, etc. Many of the current conferences are
dominated by senior investigators, and consequently, a “pre-
conference” workshop for new investigators, such as is
currently done at the Gordon Research Conference, ISRHML
and the meetings of the International Milk Genomics Consor-
tium would provide an opportunity to build community and
collaborations. Similarly, the professional societies should
develop trainee divisions, similar to that at the American
Dairy Science Association to serve the needs of new trainees
and investigators. One issue faced by the existing meetings is
that they generally address the needs of only a single
component/perspective of the lactation biology community.
After meeting in Denver to develop this white paper, it was
clear that there is a need for occasional but regularly-
scheduled, cross-disciplinary meetings that embrace the diver-
sity of perspectives and thoughts enjoyed at this conference.
Finally, a simple online “newsletter” or “blog” could be de-
veloped as a “real-time” means to share resources, ideas,
reagents, and/or problems among new and established inves-
tigators alike.
Section VI. Imperatives for Advancing the Field
There is a tremendous need for additional evidence that will
allow the clinical management of lactation and breastfeed-
ing support to be better tailored to the needs of the maternal-
infant dyad. Milk, especially human milk, is increasingly
revealed as a complex substance that exerts effects far
beyond its nutritional value. Studies of the mechanisms by
Table 1 Imperatives for future milk and lactation research
Topic Models/Priority Targets Goals
1 Milk Biochemistry Humans, dairy species Describe the structure of all human milk components as well as their variability
within- and among women; determine composition of bovine milk as basis for
substitutes.
2 Functional Properties of Milk Bioactives
Intestinal
Development
Humans, pig, tissue culture Determine the bioactive components of milk and the mechanisms of their effects
on GI development, microbiome and GALT as well as their anti-infectious
activities
Immune Tolerance Human Identify critical windows for development of immune tolerance or inflammatory
reactivity to allergens as mediated by early life nutrition
Cognitive
Development
Human, monkey, rodent, pig Investigate cognitive and behavioral development as a function of milk
constituents.
Stunting/Impaired
Growth
Undernourished infants Examine role of human milk, combined with maternal and infant interventions,
for counteracting growth stunting in developing countries and elsewhere
3 Lactation Human, rodent, monkey,
livestock, tissue culture
models
Determine molecular and cellular mechanisms by which genetic, physiologic,
environmental, behavioral, and societal factors affect mammary development,
milk production and composition with emphasis on endocrine agents and
metabolic factors.
4 Very low birth weight
infants (VLBW)
Pre-term, neonatal infants, pig Identify the components of human milk responsible for reducing the risk of
morbidities in preterm infants, the mechanisms by which they act, and the
efficacy of common practices for collecting, storing, handling and feeding
human milk for this population
5 Maternal Obesity Human, pig, rodent Understand the mechanism by which obesity affects mammary gland
development, milk secretion and milk composition; determine how
breastfeeding affects obesity programming in offspring.
6 Breastfeeding Practices
Initiation Humans, particularly at-risk
populations
Utilize quantitative methods to assess effects of obstacles to breastfeeding on
initiation of lactation and duration of breastfeeding in low income women and
women with co-existing health problems. Determine the impact of exclusive
breastfeeding beyond 12 weeks on mother and infant
Duration
Exclusivity
7 Valuation Humans Assess economic impacts via direct and indirect costs
8 Scientific
Interactions/
Training
Courses, meetings Support ongoing forums for discussion among students, researchers, and faculty;
NIH training and conference grants; increase interactions between researchers
in the human lactation and dairy fields.
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which milk components affect all aspects of infant develop-
ment are themselves in their infancy. The psychosocial
factors that affect a mother’s ability to breastfeed and the
psychological effects of the act of breastfeeding upon both
mother and infant are poorly defined. While these problems
are complex, three principles emerged from the far-ranging
discussions at this conference:
Principle 1: There is an urgent need to define the precise
function of the various components of human
and other milks as well as their interactions.
Aside from a small number of components such as lacto-
ferrin, the inter- and intra-individual variation in milk com-
position as well as the mechanisms of action of many
bioactive components of human milk remain poorly charac-
terized. Studies of these topics are crucial for understanding
how human milk facilitates resistance to infection, estab-
lishes the gut microbiota, develops the immune system and
facilitates cognitive development.
Principle 2: The role of breastfeeding in infant nutritional
status must be studied in light of the changing
dynamic between mother and child from pre-
conception through pregnancy and into post-
natal life.
It is important to recognize the intimate and integral role
of the maternal-infant biological and social unit throughout
pregnancy and through lactation and the period of comple-
mentary feeding.
Principle 3: Priority should be given to studying the im-
pact of breastfeeding in high-risk populations.
The imperatives listed in Table 1 were deemed to be
consistent with these principles and of most importance for
future research.
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